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Response: Accuracy, Arsenic,
and Cancer
Slayton et al. (1) have attempted to rebut
portions ofour EHPcommentary on arsenic
(As) cancer risk assessment (2) and some of
the debate that has emerged over such assess-
ments. In responding to Slayton et al., we
offer some additional information that inter-
ested readers may find helpful in comparing
our commentary and these responses with
Slayton et al. Our commentary drew particu-
lar attention to some obvious problems in
reported criticisms ofthe Taiwanese As expo-
sureand carcinogenesis data.
Dieary versus drinkingwaterAs in the
Taiwanese studypopulation. The cancer
slope factors for ingested As based on well
water As levels in Taiwanese studies were
challenged by Beck et al. (3) and Yost et al.
(4). They argued that their finding of inor-
ganic As in some rice and yam samples from
Taiwan required that dietAs be factored into
derivation of cancer dose-response curves.
We noted some quantitative questions about
their results. Our concerns are not trivial and
the Yost et al. findings (4) require toxicologi-
cal context and some mention of the wider
implications. Nowhere in our paper did we
argue that no inorganic As could be present
in their few samples, merely that the As frac-
tions in Yost et al. (4) appeared to differ in
some cases from otherreportedvalues.
We suggested, as one possibility, use of
different analytical methods. We also indicat-
ed that any analytical methodology involving
use ofstrong acids merits scrutiny when spe-
ciating multiple forms ofan element like As,
especially when significant fractions ofa car-
cinogenic form are being reported. How well
do such measured levels ofAs forms reflect
the original sample forms, and howwell does
in vitro chemical behavior reflect in vivo dis-
position of these forms when ingested?
Inorganic As might be liberated in analysis
but not in vivowhen ingested. WaterAs does
not offer this problem, being typically in the
inorganic form. Such differences for rice,
yams, and similar foods can be studied with
controlled-diet feeding studies in the same
waythat seafood and other marine biotawere
studied.
There are several wider potential implica-
tions ofthe Yost et al. data (4), as reported.
They may indicate the need for speciation
analyses to detect variable inorganic As con-
tent when doing risk assessments at other As-
impacted areas and communities. There may
be a need to pay much more attention to
food crops as exposure pathways for As in
these communities. Useofanalytical methods
that do not methodologically alter original
biochemicalformsmightbenecessary.
Slayton et al. (1) note the well-known
fact that strong acids do not materially break
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down organoarsenicals in seafood and they
assume that any organoarsenicals in food
items ofthe type they analyzed would behave
likewise, i.e., inorganic As is not artifactually
generated. The forms and chemical behavior
oforganoarsenicals in seafood maynot be rel-
evant to forms ofAs in their sample types .
Even within marine biota, there are major
differences in isolable organoarsenicals.
Seafood yields mainly acid-stable arsenobe-
taine and lesser levels of acid-stable arseno-
choline (5,6). Marine algae yield water-solu-
ble organoarsenicals such as 5-dimethylarsi-
noyl derivatives of 5-deoxyribosides (5-7)
andlipid-soluble forms that appear to indude
phospholipid derivatives ofthese arsenosugars
(5,8). Le et al. (9) recently showed partial
metabolic breakdown of an arsenosugar to
dimethylarsenic (DMA) in a kelp product,
nori, compared to less breakdown ofseafood
As. Isolable arsenicals are highly variable
across biota and require caution in assump-
tions about comparative behavior.
Slayton et al. accuse us ofgreadymischar-
acterizing data in two cited sources, a paper
by Pyles and Woolson (10) and a Canadian
report onAs speciation in food items summa-
rized in an EPA report (11,12). We correctly
calculated from Table 1 of Pyles and
Woolson (10) that the inorganic As content
for potato flesh in the third column (0.1
ppm) was 8% ofthe totalAs content ofpota-
to flesh reported in column 7 (1.19 ppm).
The basis ofthe incorrect value in Slayton et
al. for potato flesh is apuzzle. The dosest cal-
culation to this value for potato flesh relates
the inorganic As value of0.1 ppm in column
3 to theAs total forjust oneofthree fractions
ofthe total As, i.e., the total As of0.37 ppm
in column 2 for the methanol-water fraction,
giving about 28%. There are also the chloro-
form (column 5) and the nonextractable (col-
umn 6) phases, both presumably representing
organoarsenicals ofvarying structure and sol-
ubility. These latter two fractions contain
69% of the total As for potato flesh in col-
umn 7. People ingest all ofthe As that may
be present in their diet, not just that As frac-
tion present in analytical methanol-water
extracts.
We also did not mischaracterize the per-
cent ofinorganic As in rice or potatoes in the
cited Canadian report (11) as theywere sum-
marized in a 1988 EPA report on arsenic
(12). Table E-1, Appendix E of this EPA
report (12 dearly states that rice and pota-
toes contained 350/9 and 10% inorganic As,
respectively. We state the same values in our
paper. Data in the Canadian reportwere pro-
vided to EPA by Roland Weiler, a now-
retired member ofthe contaminant standards
staff in the Ontario, Canada, environment
ministry and a member ofthe external advi-
sory group that helped assemble the 1988
EPA report. Slayton et al. refer to a Canadian
source as not beingfamiliarwith inorganicAs
in potatoes and claim a mix-up in docu-
ments. We have no explanation for any
daimed differences in information on potato
analyses nor can we say information in the
EPA report is incorrect. Neither can Slayton
et al. note that the Pyles and Woolsen report
(10) did not indude data on rice. This is cor-
rect. We more precisely intended to compare
reported data for potatoes and not to note
anyricedatain Pyles andWoolson.
We would add an important statistical
and epidemiological pointignoredbyBecket
al. (3), Yost et al. (4), and Slayton et al. in
discussing their rice and yam data. The Beck
et al. (3) and Yost et al. (4) arguments are
based, aswe understand it, on afirstsampling
of a halfdozen rice and yam samples com-
bined. There was also a recent second sam-
pling (13) consisting, we understand, of20
samples. Such small samplings are relatively
meaningless for quantitatively characterizing
historical dietary As exposures of the huge
Taiwanese exposure population studied by
Tseng and coworkers (14,15). That riskpop-
ulation was 103,514 persons, of whom
40,421 subjects in 37 villages were studied in
a door-to-door survey (15). A total of 142
water samples from 114 wells throughout
thesevillages weretested.
Slayton et al. are incorrect in saying we
erred in noting that Beck et al. (3) excluded
As in cooking water for rice as a diet As
source because EPA already takes water used
for cooking food into account when estimat-
ingwater intakes. EPA's accounting forfood-
cooking water in its estimates of total
Taiwanesewaterintakeiswellknown andthe
1-liter estimate has been used since at least
the 1988 EPA report (12). Assigning As in
food preparation water, as EPA does, to total
water consumption rather than to As in diet
seems logical when the sole focus is total
impact ofwater As. Water As incorporated
into the diet by cooking or other means and
ingested with a meal may not have the same
bioavailability (absorption rate) asAs in water
or beverages consumed on an empty stom-
ach. This potentially alters the overall daily
water As absorbed dose. Furthermore, inges-
tion rates ofwaterAs incorporated in cooked
foods will vary with food consumption rates
rather thanwith water intake rates. WaterAs,
whendrunkdirectlyorin beverages, is appro-
priately assumed to be totally absorbed
(12,16), and such water As intake as it is
used in unit lifetime cancer risk or cancer
slope factor derivations is equivalent to
absorbed dose. Better defined analyses of
bothwateranddiet arsenicintakes in the pre-
sent contextwouldarguably result from sepa-
rating out food preparation water As from
drinkingandbeveragewaterAs.
The response ofSlayton et al. (1) to our
comment about how food As would affect
one case, an illustrative linear (regression)
dose-cancerresponsecurvebasedonwaterAs
intakes as noted by Smith et al. (17), seemed
irrelevant. They labeled this example ofours
as incorrect because their choice, amongvari-
ous curve forms still being debated, differed
from ours. This is hardly an adequate basis.
In ourexample, apositiveslope intercept rep-
resents the rate from nonwater As sources.
Anyadded, relatively stable foodAs intake in
such a linear relationship shifts the Y inter-
cept further up the ordinate. The slope
remains intact.
Water ingestion rates in As-exposed
Taiwanese. We drew attention to the EPA's
quitearbitrary useofatotaldailywaterintake
of4.5 liters among the exposed Taiwanese, a
valuesupported byBecketal. (3). We point-
ed to the need for actual water consumption
studies in Taiwan and underscored this need
bycitingstudiesshowingthatvariouspopula-
tions under diverse heat stress conditions
drink less water than they should. While any
reliable estimate of daily Taiwanese well-
waterconsumption still eludes accurate deter-
mination, we also appreciate an alternative
view that any arguments over water volume
intakes may be much ado about little. That
is, a twofold or so difference in water intake
maywell be less significant than other poten-
tial sources ofvariability and uncertainty in
any uncertainty analysis ofAs cancer risk
assessment models.
Little ofthe Slayton et al. response refutes
our principal point, and they offered inaccu-
rate or confused criticisms of our discussion
ofthis topic. Our use ofthe Guthrie estimate
ofadult water intakes (18) was to show the
good agreement between estimated and actu-
al intakes measured in the late 1970s for a
large number ofAmerican adultwomen with
diverse physical activities who were part of
the U.S. Department ofAgriculture Nation-
wide Food Consumption Survey (19).
Slayton et al. cite a very diverse mix ofstud-
ies, some ofthem cited by us aswell, indicat-
ingthatpeopleshoulddrinkmorewaterthan
they do and should follow water intake
guidelines, that they may go in and out of
voluntarydehydration, and thatpeople in hot
areas sweat. This is not new. Thefact remains
that actual field studies ofchronically heat-
stressedindividuals showpeople consume less
water than they should. For example, the
ignored studies of Kristal-Boneh et al. (20)
for adults and Phillip et al. (21) for young
children show less water consumption than
expected, casting doubt on arbitrary selec-
tionsofwaterintakevolumes.
Slayton et al. criticize our use of the
Galagan et al. study (22) in which California
children were studied in terms offluid intake
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as a function ofambient temperature. We do
not understand their problem. The Galagan
et al. paper (22) dearly states that the daily
maximum temperature was used because the
maximum was as accurate as five other forms
of reportage in depicting water intake rates
and is also the measurement most commonly
recorded in weather data. Slayton et al. daim
that drinking water was only part of fluid
intakes in these children. Ofcourse; and the
same can generally be said for Taiwan as we
discussed in detail in our paper. Finally,
Taiwanese and California children both
encounter an ambient temperature cycle,
with some maximum temperature and cooler
periods.
As measurement and intake-dependent
toxicokineties. We took strong issue with the
argument that data in the 1979 study of
Valentine et al. (23) show As intake-depen-
dent toxicokinetics and cited both analytical
methodological andmetabolicreasons. Acrit-
ical look at the methodological problems was
greatly assisted by former directorship oflab-
oratory development and application oftrace
and ultra-trace methods for such toxicants as
arsenic in blood and other media during the
time period of the Valentine et al. paper
(24-26). We noted that method limitations
make meaningless their reported data on
bloodAs forestimatingAs toxicokineticalter-
ations.
Slayton et al. (1) apparently still support
theValentine etal. study (23), buttheirargu-
ments are incorrect. The Valentine et al.
method, as described in the 1977 Kang and
Valentine paper (27), employed quite early
atomic absorption spectrometry (AAS)
instrumentation, a Perkin-Elmer Model 303
atomic absorption spectrometer in the flame
mode, As hydride generation from mineral-
ized samples, either continuous flow or gas
balloon sampling transfer modes, and 5 ml
blood samples. Their reported detection limit
was 0.02 pg (20ng)/total analyticalsamplefor
all media analyzed (27). Each oftheir blood
As analytical samples represented 5 ml of
blood. This corresponds to 4 ppb blood As
(4 pg/l). The 1977 comprehensive and con-
temporaneous review by Braman (28) for
quantitative analysis ofvarious As species via
hydride generation summarized various
papers showing sensitivity for flame AAS
analysis ofAs after hydride generation is a
lower detection limit of 5 ppb on a concen-
tration basis, similar to the reported Kang
andValentinevalue (27).
A detection limit is not a quantitation
level, which is the level atwhich one can reli-
ably or accurately quantitate the As in a sam-
ple. The quantitation level is some multiple
ofthe detection limit. A reliable quantitation
limit (RQL) would be no less than a fivefold
multiple ofthis4-ppb detection limitforvery
good current laboratory performance (29).
The 1994 methods review of Irgolic (30)
provides a detailed discussion of detection
versus quantitation limits and argues for a
quantitation limit as being no less than 10-
fold higher than the detection limit.
Experience with the topic of quantitative
methodology would certainly support
Irgolic's statement, particularly as it applied
to 1970s methodology and the Valentine et
al. (23) proficiency level therein. Overall, the
reliable or accurate quantitation limit for
Valentine et al. (23) methodology would be
either within a range of 20-40 ppb or 40
ppb, the latter based solely on Irgolic (30).
Theselimits are up to 13-fold higherthan the
3-5-ppb quantities that Slayton et al. (1) sug-
gest were being reliably or accurately mea-
sured as As exposure group means in the
Valentine et al. study (23). Put differently,
Slayton et al. would have to assume that
Valentine et al. were reliably or accurately
quantitating As content ofblood from most
of their exposure groups at or below their
reported detection limit (4 ppb) and up to
13-foldbelowtheirquantitation limit.
Slayton et al. also offer a number ofcom-
ments about detection limits for various
methods in the 1970s and methods of the
type usedbyValentine et al. (23), citingvari-
ous sources. These comments are moot, given
the reported Valentine et al. detection limit
discussed above. We are confident that their
cited review by Irgolic (31) would not con-
flict with the stated detection limit or the
Braman review (28). One reference to
extremely low As detection limits in blood
and other biological media in Slayton et al.
[Eaton etal. (29)] appearswronglycited.
The idealized case ofSlayton et al. and its
claimed ability to outperform collective
results from proficiency surveys are not fully
relevant to the paper at issue. We also note
that manylaboratories performed much more
poorly than desirable. Poor performance at
the trace and ultra-trace level was quite com-
mon in the 1970s and earlier. Proficiency
testing programs were created by professional
and public organizations to identify and
improve such lagging laboratory perfor-
mance. Weviewed the Eaton proficiency sur-
vey (29) not only as providing a comparison
forValentine et al. (23) but also as serving to
ascertain whether current proficiency, as
defined by today's criteria, permits quantita-
tive measurements ofAs in blood or other
mediaatverylowexposure levels.
We stand by our earlier conclusion that
the 3-5 ppb levels for As, cited as group
means for four of their five groups in the
Valentine et al. study (23), were at or below
their detection limits and were associated
with little more than background noise. Any
condusions drawn from that study based on
bloodAs and arguing for altered toxicokinet-
ics at low water As intakes are invalid. We
also believe that urine As-water As relation-
ships in Valentine et al. are more toxicokinet-
icallyuseful.
The role ofMMAJDMA ratios in quan-
tifying carcinogenic risk. Our paper took
issue with the view that any increase in the
ratio ofurinary MMA to DMAwith increase
in As exposure heralds increased cancer risk.
Reasons were stated and are not repeated
here. Little has been clarified on this topic
since our commentary appeared, including
the point that changes in the one known car-
cinogenic form, inorganic As, are not clearly
linked to the above ratio changes in studies
reportingsuch changes.
Slayton et al. do not provide convincing
evidence that alterations in the ternary inor-
ganic As-MMA-DMA relationship are
quantitatively linked to cancer risk character-
ization or that the biomolecular mechanisms
ofAs carcinogenesis compel acceptance of
increased cancer risk when the MMA and
DMA forms begin to undergo moderate
change in relative distribution. They cite
some new conference presentation material
and an older occupational exposure study by
Yamauchi et al. (32). With regard to the
chronic high inorganic As exposures in occu-
pational settings and methylated As urinary
profiles in workers, the 1986 study ofVahter
(33) showed that the percent inorganic As in
smelter workers' urine samples was virtually
identical to the inorganic fraction of urines
ofa nonworker population ofnonfish eaters,
18 and 19% respectively. We calculated the
corresponding ratios of percent MMA to
percent DMA as 0.25 and 0.33, respectively,
a quite modest change. Slayton et al. note
that cutaneous changes were linked to
changes in MMA:DMA ratios in the confer-
ence presentation of Del Razo et al. (34),
which we also discussed. This finding
requires further clarification and peer-review
publication as to the nature of the skin
changes and strength ofthe association with
metabolites and, especially, relationship to
the urinary inorganicAs content.
Slayton et al. cite a 1995 As conference
presentation by Hopenhayn-Rich et al. (35)
as showing an increased MMA:DMA ratio in
exposed northern Chilean subjects; however,
the full paper by these investigators (36)
makes clear that interindividual ratio differ-
ences were within a much greater range than
were differences between exposure groups. Of
importance to our view, the exposed versus
control fractions ofinorganicAs were not sig-
nificantly different (18.4 versus 14.9%) and
not materially different, as the authors note,
from the variability seen in lower exposure
data from various other studies. The exposed
group hadwaterlevels ofabout 600 pg/l. The
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relative difference in the MMA:DMA ratio
for the exposure versus control groups as
described by these authors in their Table 2 is
1.6. This ratio ofratios is identical to whatwe
calculated for the corresponding relative dif-
ference for a study ofAs exposed subjects in
Nevada (37) discussed below, using percent-
ages offorms as calculated in our commen-
tary. This lack of change exists despite the
fact the mean water As for the Nevada expo-
sureswas almost twice the Chilean level.
Slayton et al. ignored a relevant 1994
paper cited in our commentary, Warner et al.
(37). We discussed the distributions ofinor-
ganicandmethylatedAs forms in control and
exposed subjects. Exposure was to quite high
water As concentrations (mean = 1312 pg/I),
while the corresponding MMA:DMA ratios
for exposed and control subjects were 0.32
and 0.50, which, given the small sample size
and variance, are not striking differences.
These values are for a study in which the
mean exposure (1132 pg/l) was about 50%
higher than the EPA's estimated Taiwanese
mean water exposure level for the high expo-
sure group [800 pg/l (12] and, as noted by
Warner et al. (37), well above those eleva-
tions reported for other American water As-
impacted communities. Slayton et al. cite an
animal acute dosing study by Hughes et al.
(38), which they note shows dramatic evi-
dence ofdependence ofMMA:DMA ratios
on dose. Beck et al. (3) also cited this paper;
we have already rebutted Beck et al.'s argu-
ment by noting that it had little relevance to
chronichuman exposures.
One difficulty with assigning a cancer
risk prediction role to elevated urinary
MMA:DMA ratios is the fact that this ratio
can increase through any one ofat least four
possible metabolic scenarios. Only one of
these seems to offer a readily interpretable
linkage to increased cancer risk with increas-
ing As exposure if one uses distributions of
urinary As forms. This assumes that levels of
all urinary As forms, especially those ofinor-
ganic As, are toxicokinetic correlates ofwhat
is going on in vivo in terms of carcinogenic
mechanisms. Ifone argues that this does not
apply to inorganic As, then the MMA:DMA
ratio becomes problematic as well. The case
in point is one in which the fractional
amount ofinorganic As shows a net increase
with elevated exposure, along with necessary
net reductions in the fractions ofboth MMA
and DMA. A higher inorganic As fraction in
the body increases cancer risk. However, the
extent ofnet dedine ofMMAwould be pro-
portionately less than that of DMA, owing
to a build-up ofMMAsubstrate in asequen-
tial methylation pathway where DMA for-
mation from MMA occurs and where DMA
formation is relatively more inhibited by As
than MMA formation. Such a differential
sensitivity to arsenic inhibition has been pro-
posed (39). One should then see a higher
fraction of inorganic As with increased As
intake; a higher fractional MMA:DMA ratio;
a lower fractional MMA:MMA ratio in
exposed versus less exposed; a lower fraction-
al DMA:DMA ratio in exposed versus con-
trols; and asignificantly reduced sum offrac-
tional MMA + DMA for exposed versus
nonexposed.
Currentstudies ofelevated environmental
As that report urinarymetabolites can be typ-
ified bythe north Chile report (36). Here, in
exposed subjects, one sees little increase in
fractional inorganic As; a moderately elevated
MMA:DMA ratio; a lower DMA:DMA
ratio; an elevated MMA:MMA ratio com-
pared to controls; and little change in MMA
+ DMA compared to controls. These obser-
vations mainly suggest the second ofthe pos-
sible metabolic scenarios, that is, the As
methylation capacity in these exposed
Chileans canstill deal with increased inorgan-
ic As entering the body (little increased inor-
ganic fraction), but more ofthe As methyla-
tion process ishandedoffto MMAformation
and less to DMA biosynthesis (increased
MMA:DMA and MMA:MMA; decreased
DMA:DMA; little change in MMA +
DMA). A quite similar pattern is seen with
the Nevada exposure study, using our com-
mentary calculations. At this time, a change
in the MMA:DMA ratio still appears to be a
metabolic distinction without a documented
cancerriskdifference.
Taiwanese diet methyl donors and
implicationsfor Taiwanese cancer rates.
Our commentary noted that Taiwanese
nutritional deficiencies in terms of methyl
sources cannot be identified and cited data
showing nutritional sufficiency. Using the
datafor diet methyl donors in theTaiwanese,
wecalculated asmallallocation ofdietmethyl
intake to As biomethylation, an average of
-0.7%, or a ratio ofintake to As methylation
requirement ofabout 150. This indicates a
trivial requirement for biomethylation ofAs
at high intakes when adequate intake of
methyl sources exists. The ratio is obviously
not a quantitative reflection of the status of
any specific methyl pools in the body, e.g.,
those in theliverandotherorgans involved in
As biomethylation. We can reasonably
assume, however, that metabolic pools
involved in As biotransformation are fur-
nished adequate methyl levels when diets are
replete inmethyl sources.
Slayton et al. challenged the value ofour
calculated percentage and ratio by arguing
that an animal feeding study using restricted
methyl donor diets (40), astudydiscussed by
us as well, shows that the percentage of
methyl groups allocated to As methylation is
not a useful indicator for anything. Their
arguments are not convincing. We only
addressed the specific case of the nutritional
status ofthe Taiwanese in which the ratio of
dietary methyl loading to the average As
methylation requirement was about 150.
They daim that ratios of67-100 in the rab-
bits were linked to reduced methylating
capacities; that may well be the case. We
never said or implied that such ratios would
not be linked to a reduction of methylation
capacity. We also note that their calculated
ratios of67 and 100 in the rabbits are only
45% and 67% ofthe 150we estimated for an
average of the high As exposure group for
methyl donor-adequate Taiwanese. These
could be significant decrements in terms of
multiorgan methyl pool changes.
Their comments, however, indirectlysug-
gest to us a means to more precisely relate
dietary methyl status to metabolism ofAs.
One can expand the Vahter and Marafante
approach (40) to indudestudieswith a much
larger number ofdiet methyl loadings andAs
exposures. Any resulting changes in urinary
metabolite profiles from use ofa wide range
ofratios ofmethyl availability to As methyla-
tion might be useful for modeling onset of
altered methylation, the rate of altered
methylation, the toxicokinetic nature of the
associated curves, etc. Any such change can
be viewed as factorial: dietary methyl being
variable with stable As exposure, fixed diet
with As exposure being variable, or both
changing together. Slayton et al. state that
methylation ofAs in the rabbit study of
Vahter and Marafante (40) requires 0.3% of
the methyl donor intake of donor-replete
diets to methylate theAs dose, equivalent to a
ratio of 330. The corresponding Slayton et
al. estimate of a ratio of 77 in restricted
methyl intake animals is associated with a
40% decline in DMA (65% to 39%).
Therefore, a fourfold decline in the methyl
intake-As methylation ratio from 330 to 77
produced a 40% DMA decline. Onset of
altered DMA formation occurs within this
range forthisparticularsetoftestconditions.
Is such an approach relevant to the envi-
ronmental epidemiology ofnonoccupational
populationswith chronicAs exposure? This is
not clear. MMA and DMA distributions in
animals differ to some degree from that in
humans, the latter having more MMA (41).
There are also the questions of whether
altered ratios of MMA to DMA universally
occur with exposure changes and what the
relevance is ofsuch ratio changes to cancer
risk, as discussed above. As a method for dar-
ifying some issues, however, we believe it
would be ofinterest to carry out careful stud-
ies of the individual and group nutritional
status in those populations currently being
studied, in terms of daily dietary methyl
intakes and the relationship ofsuch intakes to
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both waterAs exposure levels (ratios) and uri-
nary As profiles. Our ratio of approximately
150 for the highest exposure mean (800 pg/l)
in the earlier Taiwanese subjects could be a
point ofdeparture in such studies.
Paul Mushak
PB Associates
Durham, North Carolina
Annemarie F. Crocetti
Consultant in Nutrition Epidemiology
NewYork, NewYork
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